Log in
Stimulant laxative

Castor oil

Castor oil is a vegetable-derived stimulant laxative containing ricinoleic acid, used primarily for complete bowel evacuation before diagnostic or surgical procedures. It acts on the small intestine to promote fluid secretion and peristalsis. The most testable fact is that castor oil is hydrolyzed by pancreatic lipase to ricinoleic acid, the active metabolite responsible for its cathartic effect.

Practice questionsHigh-yield facts
Drug classStimulant laxative (ricinoleic acid prodrug)
MechanismRicinoleic acid stimulates intestinal secretion and motility
Main usesBowel preparation, constipation, labor induction
Key adverse effectSevere abdominal cramping and dehydration
6 min readFor medical studentsUpdated 2026-10-14

Mechanism of action

Castor oil is a triglyceride extracted from the seeds of Ricinus communis. After oral administration, pancreatic lipase hydrolyzes castor oil in the small intestine to glycerol and ricinoleic acid, an 18-carbon hydroxylated fatty acid that is the pharmacologically active component.

Ricinoleic acid exerts its laxative effect through multiple mechanisms:

  • Stimulation of adenylyl cyclase and prostaglandin E2 synthesis in enterocytes, leading to increased intracellular cyclic AMP and activation of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel
  • Net fluid secretion into the intestinal lumen by reducing sodium and water absorption and promoting chloride and water secretion
  • Direct stimulation of intestinal smooth muscle, increasing peristaltic activity throughout the small and large bowel
  • Alteration of intestinal permeability, allowing increased passive flux of water and electrolytes

The effect is primarily in the small intestine, distinguishing castor oil from bisacodyl and senna, which act predominantly in the colon. Onset of action is typically 2–6 hours, faster than most other laxatives due to small bowel activity.

High-yield for exams
  • Castor oil is hydrolyzed by pancreatic lipase to ricinoleic acid, the active laxative metabolite.
  • Ricinoleic acid stimulates intestinal fluid secretion and peristalsis primarily in the small intestine.
  • Onset of action is 2–6 hours, faster than colon-acting stimulant laxatives like senna.
  • Common adverse effects: severe abdominal cramping, nausea, profuse diarrhea, and dehydration.
  • Chronic use causes cathartic colon (atonic, dilated colon) and laxative dependence.
  • Contraindicated in intestinal obstruction, inflammatory bowel disease, and early pregnancy.
  • Historically used for labor induction due to prostaglandin E2 release; not evidence-based or FDA-approved.
  • Hypokalemia from castor oil increases digoxin toxicity risk.

Indications

Castor oil is used for:

  • Bowel preparation before radiologic examination (barium studies), colonoscopy, or abdominal surgery—provides rapid, complete evacuation
  • Acute constipation relief when rapid catharsis is needed and gentler agents have failed
  • Labor induction in traditional obstetric practice (off-label, limited evidence)—ricinoleic acid may stimulate prostaglandin release and uterine contractions
  • Poisoning or overdose management in select cases requiring gut decontamination (rare, largely replaced by activated charcoal)

Castor oil is not recommended for chronic constipation due to the risk of dependence, electrolyte disturbances, and more effective, better-tolerated alternatives. It is rarely used in modern clinical practice except for bowel preparation in resource-limited settings.

Pharmacokinetics

  • Absorption: Castor oil itself is not absorbed. Hydrolysis by pancreatic lipase in the duodenum and jejunum releases ricinoleic acid, a small fraction of which is absorbed and undergoes enterohepatic circulation. Most ricinoleic acid remains in the gut lumen to exert local effects.
  • Onset of action: 2–6 hours orally; faster than most laxatives due to small intestine targeting.
  • Duration: Single-dose cathartic effect lasts 6–12 hours; bowel evacuation is typically complete within 8 hours.
  • Metabolism: Ricinoleic acid that is absorbed is conjugated in the liver and excreted in bile. Unabsorbed ricinoleic acid is eliminated in feces.
  • Excretion: Primarily fecal; minimal renal involvement.

No significant accumulation occurs with single-dose use. Repeated dosing can lead to fluid and electrolyte depletion.

Adverse effects

Castor oil is associated with significant gastrointestinal adverse effects:

Common

  • Severe abdominal cramping and colic—due to intense peristaltic stimulation
  • Nausea and vomiting—particularly at higher doses or on an empty stomach
  • Diarrhea with fluid loss—can be profuse and lead to dehydration
  • Electrolyte disturbances: hypokalemia, hyponatremia, hypocalcemia, and hypomagnesemia with excessive use or in vulnerable populations (elderly, children)

Serious

  • Dehydration and prerenal azotemia—from massive fluid loss
  • Intestinal obstruction or perforation—rare, in patients with underlying bowel pathology (strictures, inflammation)
  • Uterine contractions and potential preterm labor—when used in pregnancy, especially near term
  • Malabsorption and steatorrhea—with chronic use, due to impaired fat digestion and epithelial damage
  • Laxative dependence—chronic use can reduce colonic motility and worsen constipation (cathartic colon)

Rare

  • Allergic reactions: urticaria, anaphylaxis (castor bean allergen contamination)
  • Rectal irritation or proctitis—with rectal administration (uncommon route)

Castor oil should be used sparingly and avoided in chronic settings due to the high incidence of adverse effects.

Contraindications and warnings

Absolute contraindications

  • Intestinal obstruction or suspected obstruction (mechanical or paralytic ileus)
  • Acute abdominal pain of unknown origin, including appendicitis, diverticulitis, or peritonitis
  • Inflammatory bowel disease (Crohn disease, ulcerative colitis)—risk of toxic megacolon or perforation
  • Pregnancy (first and second trimesters)—may induce uterine contractions and preterm labor
  • Severe dehydration or electrolyte imbalance
  • Hypersensitivity to castor oil or castor bean components

Warnings and precautions

  • Use in pregnancy near term: Historically used for labor induction, but safety and efficacy are not well established; may cause meconium passage and fetal distress. Not FDA-approved for this indication.
  • Elderly and pediatric populations: Increased risk of dehydration and electrolyte disturbances; use with caution and ensure adequate hydration.
  • Chronic use: Avoid—can cause cathartic colon (atonic, dilated colon with impaired motility) and laxative dependence.
  • Drug interactions: May reduce absorption of fat-soluble vitamins (A, D, E, K) and medications taken concurrently due to rapid transit and altered intestinal environment.
  • Nausea/vomiting risk: Administer on an empty stomach or mix with juice to improve palatability and reduce nausea.

Castor oil is generally considered a last-resort laxative in modern practice.

Drug interactions

  • Fat-soluble vitamins (A, D, E, K): Castor oil may impair absorption and promote loss through rapid intestinal transit. Avoid concurrent administration; separate by at least 2 hours if necessary.
  • Oral medications: Rapid bowel transit and increased fluid secretion can reduce absorption and efficacy of concurrently administered drugs, particularly those with narrow therapeutic windows (anticoagulants, antiepileptics, oral contraceptives). Administer other medications at least 1–2 hours before castor oil or defer until after bowel evacuation is complete.
  • Other laxatives: Additive effects increase risk of severe diarrhea, dehydration, and electrolyte imbalance. Avoid concurrent use.
  • Diuretics: Concomitant use increases risk of hypokalemia and dehydration. Monitor electrolytes closely.
  • Digoxin: Hypokalemia induced by castor oil increases risk of digoxin toxicity. Monitor potassium levels and digoxin concentrations.
  • Corticosteroids or amphotericin B: May exacerbate potassium loss. Monitor electrolytes if co-administration is unavoidable.

No formal drug interaction studies exist for castor oil, but mechanistic interactions related to altered absorption and electrolyte disturbances are clinically relevant.

Clinical pearls

  • Castor oil is hydrolyzed to ricinoleic acid, the active laxative metabolite; this distinguishes it from direct-acting stimulant laxatives like bisacodyl.
  • Acts primarily in the small intestine, unlike most stimulant laxatives (senna, bisacodyl) that target the colon—explains its faster onset (2–6 hours).
  • Not recommended for routine constipation—reserved for bowel preparation or acute, severe constipation unresponsive to gentler agents. Modern practice favors polyethylene glycol solutions for bowel prep.
  • Historical use in labor induction: Ricinoleic acid stimulates prostaglandin E2 release, promoting uterine contractions. Evidence is limited, and safety concerns (meconium passage, dehydration) make this practice outdated.
  • Cathartic colon: Chronic use leads to atonic colon with impaired motility—laxative dependence ensues.
  • Palatability issue: Castor oil has an unpleasant taste and viscosity; administer chilled or mixed with juice (orange juice is traditional) to improve tolerance and reduce nausea.
  • Ricin toxin is NOT in castor oil: Ricin, a deadly toxin from castor beans, is a protein that does not partition into the oil during extraction. Castor oil is safe when properly manufactured.
  • Pediatric use: Rarely indicated; if used, ensure careful fluid and electrolyte monitoring. Gentler osmotic laxatives (lactulose, PEG) are preferred.
  • Exam associations: Castor oil is classically tested as a ricinoleic acid prodrug, a small intestine stimulant, and a cause of severe cramping and hypokalemia with overuse.

Practice questions

1. A 58-year-old woman with chronic constipation presents for evaluation. She reports using castor oil daily for the past 3 years. Colonoscopy reveals loss of haustral markings and an atonic, dilated colon. Laboratory studies show potassium 3.0 mEq/L (normal 3.5–5.0). Which of the following best describes the mechanism underlying her colonic findings?

Answer: B. This patient has cathartic colon from chronic castor oil use. Chronic stimulant laxative use damages the myenteric plexus, leading to colonic atony and loss of haustral markings. Hypokalemia results from chronic diarrhea. Direct epithelial toxicity does not cause the characteristic atonic, dilated colon. Ischemia and autoimmune processes are not associated with laxative abuse.

2. A 32-year-old woman at 38 weeks' gestation is encouraged by a family member to drink castor oil to induce labor. She asks her obstetrician about this approach. Which of the following mechanisms best explains the purported labor-inducing effect of castor oil?

Answer: C. Ricinoleic acid, the active metabolite of castor oil, stimulates prostaglandin E2 synthesis. Prostaglandin E2 promotes uterine contractions and cervical ripening, explaining the traditional use of castor oil for labor induction. However, this practice is not evidence-based or FDA-approved and carries risks including maternal dehydration and meconium passage. Castor oil does not act on oxytocin receptors, progesterone, or cortisol pathways. Increased abdominal pressure is not the mechanism.

3. A 45-year-old man undergoes colonoscopy after taking castor oil for bowel preparation. During the procedure, he develops severe cramping and profuse watery diarrhea. Laboratory studies reveal sodium 132 mEq/L, potassium 2.8 mEq/L, and creatinine 1.6 mg/dL (baseline 0.9 mg/dL). Which of the following best explains the patient's hypokalemia?

Answer: A. Profuse diarrhea from castor oil causes fecal potassium loss through aldosterone-independent colonic potassium secretion, leading to hypokalemia. The elevated creatinine indicates prerenal azotemia from dehydration. Volume depletion typically activates the renin-angiotensin-aldosterone system, which would promote renal potassium retention, not excretion. Metabolic alkalosis is not the primary mechanism here. Rapid transit reduces absorption of all nutrients, but fecal losses dominate. Castor oil does not cause renal tubular acidosis.

Frequently asked questions

How does castor oil work as a laxative?

Castor oil is hydrolyzed by pancreatic lipase in the small intestine to ricinoleic acid, which stimulates intestinal fluid secretion and peristalsis. Ricinoleic acid activates adenylyl cyclase and prostaglandin E2 pathways, increasing cyclic AMP and promoting chloride and water secretion into the gut lumen. It also directly stimulates smooth muscle contraction, resulting in rapid bowel evacuation within 2–6 hours.

What are the side effects of castor oil?

Common side effects include severe abdominal cramping, nausea, vomiting, and profuse diarrhea. Serious adverse effects include dehydration, electrolyte disturbances (especially hypokalemia), and potential uterine contractions in pregnancy. Chronic use can lead to laxative dependence and cathartic colon (loss of normal colonic motility). Castor oil is not recommended for long-term use due to these risks.

Is castor oil safe during pregnancy?

Castor oil is contraindicated in early pregnancy and should be used with caution near term. Ricinoleic acid can stimulate prostaglandin E2 release, leading to uterine contractions and potential preterm labor. Historically used for labor induction, it is not FDA-approved for this purpose and carries risks including meconium passage and maternal dehydration. Pregnant patients should consult their obstetrician before using castor oil.

Castor oil vs mineral oil — what is the difference?

Castor oil is a stimulant laxative that is hydrolyzed to ricinoleic acid, which actively promotes intestinal secretion and motility in the small intestine, with onset in 2–6 hours. Mineral oil is a lubricant laxative that softens stool by coating it and reducing water absorption in the colon; it acts more slowly (6–8 hours) and does not stimulate peristalsis. Castor oil causes more cramping and is used for rapid bowel evacuation, while mineral oil is gentler and used for chronic constipation.

What is cathartic colon and how is it related to castor oil?

Cathartic colon is a condition caused by chronic laxative abuse, characterized by an atonic, dilated colon with impaired motility and loss of haustral markings on imaging. Long-term use of stimulant laxatives like castor oil damages the myenteric plexus, leading to dependence and worsening constipation. Treatment involves discontinuing the laxative and implementing bowel retraining.

Conditions it is used for

ConstipationBowel preparationFecal impaction
BisacodylSennaDocusateMineral oilPolyethylene glycolLactuloseMagnesium citrateLubiprostone

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A06AB05

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.